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ABSTRACT
After a patient’s breast cancer diagnosis, identifying breast cancer lymph node metastases is one
of the most important and critical factor that is directly related to the patient’s survival. The
traditional way to examine the existence of cancer cells in the breast lymph nodes is through a
lymph node procedure, biopsy. The procedure process is time-consuming for the patient and the
provider, costly, and lacks accuracy as not every lymph node is examined. The intent of this study
is to develop an artificial neural network (ANNs) that would map genetic biomarkers to breast
lymph node classes using ANNs. The neural network classes were adopted from the American
joint committee on cancer materials pathologic lymph node statuses. Twenty gene biomarkers
were selected based on a hybrid feature selection model, and the neural network parameters were
configured using hyperparameter tuning techniques targeting the neural network capacity,
activation function, weight initialization, and the neural network learning rate and momentum. The
METABRIC breast cancer data set was used to train, validate, and test the neural network. The
results show an accuracy of 96% for the training dataset and 85% for both the validation and test
dataset. As far as the area under the curve (AUC), the neural network scored 100% for the training
dataset, 95% for the validation, and finally, 90% for the test dataset. This study directly benefits
and supports the cancer organizations transition from identifying cancer based on the organ in the
patient’s body, where cancer first starts to develop as well as the shape of cancer under a
microscope, to grouping cancer cells based on gene mutations. This change in cancer identification
will assist the providers in improving the diagnosis, prognosis, and treatment of cancer patients.
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CHAPTER 1: INTRODUCTION
1.1 Overview
The extent of axillary lymph node involvement is one of the most important prognostic indicators
in breast cancer (Shen, 1991). The first place that breast cancer spread is the lymph nodes around
the breast, and the risk of axillary lymph node metastasis increases as tumor size increases(Jatoi et
al., 1999). Sentinel node biopsy is the most common way to check the axillary lymph nodes for
cancer (Harris et al., 2012). The number of cancerous lymph nodes is associated with survival rate.
Tonellotto et al. reported that a higher number of positive lymph nodes and lymph node ratio are
associated with shorter disease-free survival and overall survival times (Tonellotto et al., 2019).
In this work, using the American joint committee definition of cancer regional lymph nodes
(Giuliano et al., 2017), we analyze the gene expression of different lymph nodes cancer definitions
(classes). The work aims to find a potential set of biomarkers for each class and to build a machine
learning model that can predict the outcomes of cancer spread among the lymph nodes based on
genomics.

Machine learning models have been proposed to predict the outcomes of breast cancer (Tabl et al.,
2019 , Jubair et al., 2020 , Bejnordi et al. , 2017). Abou Tabl et al. proposed a hierarchical machine
learning model to predict breast cancer survival for specific therapy. The model analyzed the gene
expression of a cohort of breast cancer patients to find gene biomarkers for each therapy for the
time window of five-year survivals (Tabl et al., 2019). Jubair et al. studied the ten breast cancer
subtypes for the same window of survivals (Jubair et al., 2020). Both machine learning models
were built on a METABRIC dataset with a cohort of more than 2,000 patients' gene expression
profiles (Cruz and Wishart, 2006).

Bejnordi et al. (Bejnordi et al., 2017) surveyed deep learning models to predict the lymph nodes
metastasis based on lymph node images. The method was applied to the CAMELYON dataset
(Kourou et al., 2015) that contains 1,399 annotated whole-slide images (WSIs) of lymph nodes,
both with and without metastasis. They assessed the performance using the area under the receiver
operating characteristic curve (AUC) for the algorithms ranged from 0.556 to 0.994.
1

This study proposes a hierarchical machine learning model to find the subset of genes that can
serve as biomarkers to predict different breast cancer lymph node stages. To the best of our
knowledge, this is the first study to classify the lymph node classes based on gene expressions.
The potential biomarkers may help in the diagnosis and treatment of the disease.

1.2 Problem Statement
Traditional medical diagnosis and prognosis methods for breast cancer lymph nodes metastasis
suffer from low detection level, lack of accuracy, and are costly.

1.3 Research Objective
Develop a novel machine learning model to identify gene biomarkers for breast cancer lymph
nodes metastasis to improve detection and diagnosis in predicting the likelihood of breast cancer
patients developing lymph nodes metastasis.

1.4 Research Gaps and Novelty
Based on the conducted literature review Table 1.1, it is evident that a gap exists in which there is
no reported method in the literature, to the best of our knowledge, that focused on the use of gene
expression to identified axillary lymph nodes stage/status.
Table 1.1 illustrates the most relevant research subjected to the field of machine learning in cancer
prediction, the highlighted red cells represent areas that were not part of the research focus, and by
cross-checking, we can conclude that none of the research utilized genetics and machine learning
methodologies to identify breast cancer lymph nodes metastasis.
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Table 1.1 Literature review gap analysis table.



Areas of focus
Areas out of resarch focus ( Gap)

1.5 Research Hypothesis
A set of genetic biomarkers are sufficient in identifying and predicting the likelihood of a breast
cancer patient developing cancer cells in the lymph nodes and the stage of the patient’s breast
lymph node.
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CHAPTER 2: LITERATURE REVIEW
2.1 Informatics
The world of informatics consists of many subdisciplines, such as health informatics, biomedical
informatics, bioinformatics. Health informatics, also referred to as biomedical informatics, is an
interdisciplinary field that leverages enormous quantities of data produced by medicine and healthfocused research. For example, eliminate prescription errors, expand access to healthcare, find new
uses for old drugs, lower hospital readmission rates, make medical records more accessible…etc.
(Coiera, 2015). In addition, biomedical informatics analyzes bioinformatic data sets to alter
treatments for patients and restructure care processes in healthcare systems (Lorenzi and Riley,
2013).

The new surge of information and data from sequences and functional genomics has led to the
development of a new field, bioinformatics. Bioinformatics, in essence, is a field that joins
components of biology and data analysis (Baxevanis et al., 2020). According to the department of
molecular biophysics and biochemistry at yale university that in April of 2001, the repository of
nucleic acid sequences at the GenBank had 11,546,000 genetic data points, and that these
databases, on average, doubles in size in less than 15 months. Figure 2.1 summarizes the prompt
rise of activity in machine learning between 2010 and 2015 years in terms of the number of
publications in sub-fields in health informatics, including bioinformatics, medical imaging,
pervasive sensing, medical informatics, and public health (Ravì et al., 2016).

Figure 2.1 Distribution of publications in health informatics subfields (Ravì et al., 2016).
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Bioinformatics has three main objectives; the first objective is to present the data in a meaningful,
organized way to allow researchers to utilize, the second objective is to develop tools to support
research in analyzing the available data and finally the third objective is developing tools that are
not only limited to support researchers in their analysis but to perform the analysis and guide and
present to the researcher’s meaningful results. Luscombe et al. concluded in their research that
analyses in bioinformatics primarily concentrate on three main types of datasets with regards to
molecular biology; the first dataset is macromolecular structures, followed by genome sequences,
and finally of functional genomics experiments (Barnes and Gray, 2003).

2.2 Artificial Intelligence in the Medical Field
Artificial intelligence is an element of computer science that seeks to make systems more
intelligent. In the medical field, AI can be subcategorized into three main categories. The first is
Artificial intelligence for medical diagnosis. This category refers to building an AI model that
determines which disease or condition explains a person's symptoms and signs (Kononenko,
2001). The second is Artificial intelligence for medical prognosis, and this refers to building an AI
model predicting the likely or expected development of a disease, including whether the signs and
symptoms will improve or worsen (and how quickly) (Kourou et al., 2015). Finally, Artificial
intelligence for medical treatment and refers to building an AI model that estimates the effects of
particular treatments on a given patient (Chernozhukov et al., 2018).
Figure 2.2 demonstrates the relationship between artificial intelligence, machine learning, and
learning techniques. Machine learning is one of the major subsets of artificial intelligence, and it
is one of the most rapidly developing subfields of AI research. ML uses statistical methods to
enable machines to improve with experience.

5

Figure 2.2 Diagram to explain the relationship between AI, ML, and Learning techniques.

One of the fundamental requirements for any intelligent behavior is learning. It is well accepted
that there is no intelligence without learning (Michalski et al., 1998). There are multiple learning
techniques using in machine learning, and that’s because different algorithms solve various
problems. Algorithms are grouped in two different fashion. First algorithms are grouped by
learning styles such as supervised learning, unsupervised learning, and reinforcement learning.
Second, algorithms can be grouped by the type of problems, such as classification, regression,
optimization, and other groups of algorithms. Figure 2.3 illustrates examples of learning
techniques and how they interact with one another (Kourou et al., 2015).

6

Figure 2.3 Examples of learning techniques.

2.3 Machine Learning in Cancer Prognosis
Machine learning is a tool that is increasingly being used to evaluate complex problems in ways
that replace human manual decision-making by using statistical methods and mathematical
relationships to make decisions. Machine learning can occur in one of three ways: supervised
learning, semi-supervised, or unsupervised learning. Supervised learning consists of an instructor
providing the algorithm with training examples that are labeled (Cruz and Wishart, 2006).
The model can then evaluate the taught relationships and, when given a new set of inputs, predict
the classifications within that data as well. In unsupervised learning, the ML model is given
unlabeled training data and then evaluates the relationships and patterns independently. Selforganizing feature maps (SOMs), hierarchical clustering, and K-means clustering algorithms are
examples of unsupervised ML programs (Cruz and Wishart, 2006).
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ML for detecting and diagnosing cancer has been used since the 1980s, but its use for the prediction
and prognosis of cancer was not widespread until the turn of the 21st century (Cruz and Wishart,
2006). There are several prominent machine learning (ML) techniques used in the prediction and
prognosis of cancer: artificial neural networks (ANNs), support vector machines (SVMs), decision
trees (DTs), and byesian networks (BNs), among other, less commonly used methods. Of these,
ANNs are the most commonly used, making up nearly 70% of the literature base for predicting
cancer using ML methods, This was followed by the use of SVMs (9%) and, subsequently, by
other methods (Cruz and Wishart, 2006).

ANNs have long been used to evaluate patterns of classification and data relationships in specific
sets of data. “Hidden layers” complete the complex calculations that are used to identify
relationships and thus make predictions. Some major drawbacks of ANNs include being what is
characterized as a “black-box” technology. Due to the calculations being completed in hidden
layers, it can often be impossible to evaluate why certain classifications are made or to troubleshoot
the model if it is erroneous (Kourou et al., 2015). SVM, despite being far less frequently applied
than ANNs, are the next most commonly applied cancer prediction and prognosis method in the
literature. It is a promising ML method that, in some cases has shown the ability to outperform
other ML methods in terms of accuracy, sensitivity, specificity, and precision (Asri et al., 2016).
SVMs map inputs and then increase the dimensionality of the system in order to isolate different
classifications.

A hyperplane is then applied in such a way as to maximize the separation from each classification
of training data. This hyperplane then acts as a classification boundary for the model (Kourou et
al., 2015). Decision Trees, a long-used tool that can be manually constructed by experts, can also
be generated by ML and has shown some use in predicting cancer (Cruz and Wishart, 2006).
Decision trees build the regression model by classifying the inputs into a tree-like configuration,
in which the inputs are subcategorized into subsets followed by smaller subsets resulting into a
final tree structure with decision nodes and leaf nodes (Kourou et al., 2015).

Instead of classifying data outright, Bayesian Networks create probability estimations in a
directional acyclic graph, which can then be used to determine the probability of a specific outcome
8

(Kourou et al., 2015). Based on the classification of a number of values, a Bayesian Networks may
determine, for example, the probability that a tumor is malignant.

2.4 Gene and Cancer
Cancer is predominantly a genetic disease. According to the Canadian cancer society (Canadian
Cancer Society, 2021), All cancers are caused by a change in genes or damage to genes. It typically
begins when a single cell develops a series of mutations that cooperatively change a normal cell
into a cancerous cell that divides hysterically and ultimately spread all through the human body
(Van't Veer et al., 2002). Gene mutations linked with cancer can be transmitted through the
germline, or they can be gained through bodily mutations. It requires time for a cell to accumulate
all of the mutations needed to become cancerous (Davies et al., 2002). That’s why it is a higher
risk of developing cancer as we get older.

Tumor suppressor genes and proto-oncogenes are the two types of genes that drive cancer, and
mutations in any of these types of genes would lead to cancer (Chial, 2008). Tumor suppressor
genes were discovered by Alfred Knudson through his research around the inheritance of
retinoblastoma, a childhood form of retinal cancer (Knudson, 1971). Tumor suppressor genes are
genes that slow down or stop cell differentiation, repair DNA, or programmed cell death, where it
triggers the cell to die. Any mutation to the tumor suppressor genes, cells can grow out of control,
DNA will malfunction, which in turn will lead to cancer (Weinberg, 1991). Proto-oncogenes are
genes that work in contrast to tumor suppressor genes in which the proto-oncogenes inhibits cell
differentiation, increase cell division and prevent cell death (Morgan and Curran, 1991).

In recent research that is considered a breakthrough by Emily golden et al. at the Harry Perkins
Institute of Medical Research at the University of Western Australia's Associate (Golden et al.,
2021), they have discovered a single breast cancer-causing gene. This discovery could
significantly improve the treatment of breast cancer patients, as they were able to identify the
protein within the gene that protects the cancer cells from traditional cancer treatments such as
hormone treatments. The study was conducted on data from an American study of breast cancer
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in which they compared the hormone-driven cancers with the worst survival chance against the
ones with high survival chances.

2.5 Axillary Lymph Nodes Metastasis
There are more than 600 Lymph nodes in the human body, with approximately 20 nodes in two
clumps in each armpit surrounding the breast area (Frederick et al., 2002). Lymph nodes are the
body’s immune system’s first line of protection, and they are linked to one another by lymph
vessels that carry a clear, watery liquid that passes through the nodes, also called lymph fluid. The
lymph nodes contain two types of cells (lymphocytes) -- B-lymphocytes, also known as B-cells,
and T-lymphocytes, also known as T-cells. The B-cells are responsible for building antibodies that
attach themselves to germs, bacteria, or viruses and trigger and notify the immune system to know
they need to be eliminated. The T-cells have two primary duties first, destroy the harmful body,
and second keep track of immune cells (Edge et al., 2010).

Breast cancer cells usually spread to lymph nodes around the breast area, and the risk of axillary
lymph node metastasis increases as tumor size increases (Edge et al., 2010). Currently, the most
common way to examine the existence of cancer cells in the lymph node and evaluate the node
status is through sentinel lymph node procedure (biopsy) (Litjens et al., 2018) which is a tedious
examination process, time-consuming, and lacks accuracy as small metastases might be
overlooked.

2.6 Employing Genetic Expression in Cancer Prognosis
Patient's response to cancer treatments varies. Machine learning combined with DNA microarray
has been used to study breast cancer survivability (Ali and Feng, 2016). Abou Tabl et al. (Tabl et
al., 2019) presented in their paper “A Machine Learning Approach for Identifying Gene
Biomarkers Guiding the Treatment of Breast Cancer”, That Genetic profiling of cancer survivors
of breast cancer who received the same treatment can give clues on biological processes and
finding the right treatment. Knowing the patient genetic profile can help to find the best treatment.
The authors used a public dataset with 2,433 from breast cancer patients (Kechavarzi and Janga,
10

2014). The Samples were grouped by the type of treatment that they have received and classified
them into living patients and deceased patients. They considered the samples of the patients who
received one treatment of hormone therapy, radiotherapy, and/or surgery.

They used a hierarchy machine learning model that detects the patient's 5-year survival rate. The
classes are created using the received therapy and survivability. The therapies of interest are
hormone therapy, radiotherapy, or surgery, which in total yields six classes. The model avoided
overfitting by applying the feature selection method and then deploying the wrapper feature
selection method. After applying the feature selection methods, the selected number of samples
was narrowed down to 347 patients. It was concluded that imbalanced classes are presented in the
data set; thus, standard regression analysis will be skewed. In the first step, they used Chi-square
to restrict the quantity of important and dominating features, then the wrapper feature selection
technique was utilized to get the best-representing subset for this group. They also used minimum
redundancy and maximum relevance.

After feature selection, two class-balancing techniques were applied. The first is SMOTE method
to resample the data, and the second method is a cost-sensitive classifier to adjust the unequal
number of samples in classes before classification. To adjust all the unequal classes prior to
applying the classifiers. The authors created a tree-based model where they compare one class vs.
the others. This creates a five nodes tree. They studied 347 patients and applied a prediction method
to identify genes that can serve as strong biomarkers for better survival. The results showed that
the root node deceased and hormone (DH) gives the best score in terms of accuracy. The second
node was derived by eliminating the DH node from the data set and predicting the rest again. The
second node was deceased and radio (DR). They proceeded with such a technique and found the
third node to be living and hormone (LH), followed by the fourth node deceased and surgery (DS),
and the last node with an accuracy of 80.9%. They used different classifying methods. They found
out that the Bayesian classifier worked best for the first three nodes while the SVM polynomial
degree 3 kernels performed averagely. They performed further analysis to validate some of the
biomarkers and found a significant correlation among gene expressions on node 2 and 3.
Moreover, donated that the gene FGF16 is a gene responsible for fibroblast growth factors.
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The gene UPF3 is upregulated in cancer cells found in humans. Furthermore, the team noticed that
the ASAP1 gene is abnormally overexpressed in breast cancer cells. This gene has a high
correlation with FBXO41. On the other hand, this gene is downregulated in other nodes. Such
variances might be related to the pathogenesis of the tumor itself. The gene VAMP4 is related to
neoplastic diseases. It is shown that miRNA is involved in the development of breast cancer.
CT47A1 is a gene ever expressed in ductal carcinoma, and they found this gene in the CT class.
In the fourth node, they saw that PRPS1 was targeted by miR124 in breast cancer. In the fifth node,
the ARPC3 gene might have a role in the development of breast cancer.

To analyze the survival rate and to find the best way to deal with this illness, Abou Tabl et al. (Tabl
et al., 2018) proposed in the paper “A Novel Approach for Identifying Relevant Genes for Breast
Cancer Survivability on Specific Therapies” a method to analyze the genetic makeup of breast
cancer survivals for specific therapies. They used supervised and non-supervised machine learning
to analyze such problems. They used variables such as 5-year survival rate and method of
treatment. The study mainly focused on three therapies: hormone therapy, radiotherapy, and
surgical intervention.

The scientists run different models and different variables and found that some specific genes such
as ZC3H11A, VAX2, MAF1, and ZFP91 can serve as strong biomarkers. Vasaikar et al. (Vasaikar
et al., 2018) used a non-supervised model of machine learning and found out that the interleukin
eight genes were strongly associated with the first line of treatment. Chang et al. proposed that the
genetic factor responsible for healing wounds may be vital in cancer metastasis.
They proposed a method to analyze a sample of 295 patients with early breast cancer. It was found
out that among these patients, the ones who have a high expression of the wound healing genes
had a reduced metastasis-free survival rate and survival rate. In this study, the authors built upon
these previous studies and propose a better treatment for breast cancer patients. By using a gene
expression data-based system, they determine the appropriate therapy treatment for better
survivability of breast cancer patients. This was done by applying the greedy approach of the onevs rest model to tackle the multi-class problem. They only considered patients who lived after the
5-year mark post-treatment. They used Ward’s linkage-based hierarchical-clustering method to
discover better boundaries among the number of classes presented. The authors collected 2433
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samples from public data. They grouped them by therapy intervention and number of deaths and
survivals. The model is a bottom-up hierarchical multi-class tree. This was achieved by an
approach called agglomerative clustering. Imbalanced classes are presented in the data set, which
is a common issue to handle in machine learning classification problems. To solve this, they used
Chi-square and Info-Gain, in order to gain the finest subset of genes that best signify the model.
The wrapper method was used.

They applied the Minimum-Redundancy-Maximum-Relevance (mRMR) method. They proceeded
by applying SMOTE, cost-sensitive, and resampling to handle the class imbalance problem, and
the model proceeds with traditional algorithms that are famous for classification problems such as
Naive Bayes and Random Forest.

The model relied on standard classifiers to find out the biomarker genes that are the model relies
on upon splitting the classes for trees’ each branch. To model the traditional and famous classifier
for classification tasks, i.e., Support Vector Machine, the researchers added a library along with a
linear kernel. It was utilized inside a grid-search process or algorithm to improve and optimize the
parameters of the classifiers.
Applying the algorithm, they found that Ward’s linkage technique is the one that accomplishes
incredible accuracy on difficult multi-class classification tasks (6 classes) and yields the main
important hierarchy. Ward’s linkage yields the best functioning and the best results in terms of
accuracy(Chang and Lin, 2011). It also has a more balanced tree, which makes it easier maintaining
the different group clusters. The results show that the separation in the lower part of the tree
concerns 99% and 100% of the tree nodes.

Accuracy scores are 99.2% for DS vs. LS and 100% for DH vs. LH. The accuracy is high in the
central segment of the tree, with an accuracy of 99.5% for the right side of the tree and 99.6% for
the left side of the tree. On the root of the tree, the scores drop down. Using Ward Linkage, the
function is based on the sum square error, which reduces the in-cluster variances. This improves
classification performance (Tabl et al., 2019).
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Jubair et al. (Jubair et al., 2020), The authors of the paper “A novel approach to identify
subtype‑specific network biomarkers of breast cancer survivability”, obtained subnetworks from
the seed genes via a method used by Chuang et al. The authors used the unsupervised greedy
technique. Specified a seed gene, distance = 1, used to enhance the network from seed gene protein.
Subnetwork activity score was determined, and afterward, the activity score is discretized in
similarly divided bins. The number of bins was dictated by ⌊log2(number of tests) + 1⌋. At that
point, it determined shared data for every one of the subnetworks from the discretized common
data dependent on the class. It picks the subnetwork that has the most elevated shared data value
and again enhances the subnetwork from newly merged protein with distance = 1. The
development proceeded until it gets the planned distance from the seed gene protein more
prominent than 0.1. The data set for the study was obtained from the METABRIC dataset. It
included 1904 patients (Tonellotto et al., 2019). Among these patients, 1407 survived more than
five years, and 497 died before the 5-year mark.

The authors further separated the data into cluster subtypes. Subtype 4 had two categories estrogen
positive and estrogen negative. In total, the authors had a study group with 11 subtypes. The
appropriate gene expression was achieved by implementing Illumina HT 12. The data set had
24,368 different genes and 224,766 interactions with proteins. The authors started with one gene
at each tree split and chose a model that yielded the best geometric mean value. The calculations
were done via MATLAB. In order to handle imbalanced data, the ADASYN technique was used
(Jubair et al., 2020).

The authors used the SMOTE technique to perform oversampling (Bejnordi et al., 2017). The ChiSquare is used to measure the degree of independence and to eliminate redundant genes, and reduce
the complexity of the problem. The mRMR was a strong feature added by the scientists as it
eliminated redundancy by not factoring in correlated metagenes. The authors put the above
features together. They choose the right subnetworks from the PPI using the Chi-square.

Afterward, the mRMR feature was applied in conjunction with Random Forest to greatly decrease
the number of subnetworks. Subsequently, the authors had a clear idea of the subnetworks of
interest, and they used ADASYN to create synthetic samples for the smaller classes. If the ratio of
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living to dead classes was less than two, the scientist used the Random Forest to populate. The
selection of seed genes was made based on common genes in two datasets. They used logistic
regression to distinguish among classes. The system started with one feature until it selected all
the features. The authors used a ten-fold cross-validation method to better estimate the
performance. The geometric mean was used as the main evaluator. By itself, the geometric means
depend on the specificity and the sensitivity.

The model considered the seed genes to create metagenes that had distances of 2, 3, and 4 from
the seed root. Some metagenes are related to more than one protein as because of exon splicing,
and the same gene can code for multiple proteins. The authors found some metagenes that can
predict survivability, and they used the method proposed by Chaung et al. (Giuliano et al., 2017).
The authors did not use any class balancing techniques. The results show the network biomarkers
greatly improved, and there were obtained values of the geometric mean as high as 0.766. The
threshold for mutual information was kept at a margin of 0.1 when creating subnetworks. The
authors used the p-value hypothesis to test the null hypothesis. The hypothesis tests were used to
select or no more features of the system. The p-value was used to value each feature method
relative to the class, while the mRMR was used to identify the relationships with different features
and the subset. In the end, the authors applied a wrapper technique to achieve the absolute subgroup
of metagenes.

From the analysis, the authors saw that methods that considered class imbalances performed better.
Also, the ADASYN method was noticed to perform better by considering all seed gene distance
values. Overall, the maximum performance was achieved at a distance of 2. A major part of the
study was to determine the distance value to get the optimal performance to detect the patient’s
survivability. On most of the subtypes, value 2 of distance achieved better performance; however,
three performed well compared to the whole samples. To better evaluate the performance, it was
compared to a gene-based approach that can calculate resistance in cancer cells (Mucaki et al.,
2016). The authors' proposed method yielded improved results. They found a list of 46 genes that
best served as biomarkers. The genes of interest highly perform at making predictions about
patients who are going to live but offer weak results when trying to predict patients who are going
to die because the system does not tackle the class imbalance issue.
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The authors noticed that distance 4 offers the greatest reliability, and the UBC gene and its network
are highly correlated to survival from breast cancer. The genes SUMO1 and CHD3 and their
interactions are correlated to many types of cancer. Jubair et al. (Jubair et al., 2020) proposed a
method that predicts a set of metagenes strongly correlated to cancer survival. They used different
tools such as geometric mean to evaluate the results and p tests. The authors suggest that the
framework can be improved if it would factor in different therapies. In which a larger sample
would be needed and a wet lab test to assess all their observations.
Mendne et al. discussed in the paper titled “ Machine learning prediction of cancer cell sensitivity
to drugs based on genomics and chemical properties” (Menden et al., 2013) the possibility to
assemble a machine learning model that would be able to predict cancer cell sensitivity to drugs.
They used a detailed cancer drug screening dataset available from the “Genomics of Drug
Sensitivity in Cancer”, and they utilized the IC50 to collect the dose-response curve results. The
neural network was trained on the genomic information for each cell. As far as the target class,
they used microsatellite instability status (1 and 0 to represent unstable and stable respectively),
somatic coding variant (1 and 0 to represent the change in the protein sequence of or wild type),
gene amplification and deletion of those cancer genes (1 = amplification/more than seven copy
numbers, 0 = wild type/between 1 or 7 copy numbers, and –1 = deletion/no copy number). The
team concluded that the cell sensitivity to the drug is driven by both features from the cells
(features connected to the inner workings of the cell) and the drugs (physicochemical properties
that are linked with the capability of the gene to cross the cell membrane) (Menden et al., 2013).
Litjens et al. used lymph node slide image dataset in their research titled “1399 H&E-stained
sentinel lymph node sections of breast cancer patients: the CAMELYON dataset” in order to build
a convolution neural networks that are capable to automatically detect cancer metastases in lymph
nodes with high accuracy (Litjens et al., 2018). The CNN model was trained and validated on
1,399 whole slide images of lymph nodes with both metastases and normal cells. The node status
was used as the target class. The results show promise and a high potential for re-use.
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2.7 Multi-omics Data
Multi-omic is a data approach where multiple omics groups are combined for data analysis. The
first omic dataset is genomics. Genomics is a dataset that involves genes and genetic variants
related to a disease, treatment, or medication (Vasaikar et al., 2018). The second dataset is
epigenomics, which is a dataset involving modification to the DNA or associated proteins. The
third dataset is transcriptomics; transcriptomics is a dataset that identifies the qualitative and
quantitative RNA levels in the genome (Curtis et al., 2012). The fourth dataset is proteomics;
proteomics is a dataset that identifies the qualitative and quantitative protein levels in the genome.
Finally, the fifth omic dataset is microbiomics, and from the name, microbiomics consists of all
the microorganisms (Curtis et al., 2012).

Depending on what data type is used (or omitted), the model may or may not be widely applicable.
For example, a model that uses data for cancer survivability but fails to account for other variables
related to death (e.g., blood clots) may suffer from inaccuracy that consequently reduces its value
(Kourou et al., 2015). There is an extremely wide range of data types available in the prediction
and prognosis of cancer, and recent papers have claimed successful prediction using a wide array
of inputs. Depending on what prediction is trying to be made, single nucleotide polymorphism
(SNP), genomic, pathological data, clinical data, and other macro-scale and micro-scale data have
all been used (Kourou et al., 2015). These can be applied to predictions about cancer susceptibility,
cancer recurrence, and cancer survivability.
The METABRIC database used in this study is a genomics dataset. The data is from an openaccess source, cBioPortal (Cerami et al., 2012, Gao et al., 2013). The database provides highquality access to molecular profiles and clinical attributes from large-scale cancer genomics
projects.
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CHAPTER 3: METHODOLOGIES
3.1 Icam DEFinition for Function Modeling (IDEF0)
The IDEF0 model in Figure 3.1, as well as the detailed IDEF0 model in Figure 3.2, will be utilized
as the process modeling steps to be followed for the rest of the research. IDEF0 Model is used to
illustrate the inputs, controls, mechanism, and finally, the output. In the classification model,
clinical and genetics data are the main inputs into the supervised model. Learning Techniques that
include ANN, SVMs, decision trees (DTs), and finally, the Bayesian networks (BNs) algorithm;
programming tools such as python, KNIME, and weka; and finally parameter hyper tuning, all will
represent the mechanism in the modeling process. The model is controlled by a time, data
availability, and classification key performance indicator that includes accuracy, F-measures,
number of correctly/incorrectly, sensitivity, and specificity measures. Finally, the desired output
would be a set of breast lymph nodes gene biomarkers as well as a real-time decision-making tool.

Performance
Time

Data availability

Breast Lymph Nodes Gene
Clinical Data
Genetics Data

Biomarkers

Data
Classification
A0

Python/Weka

Lymph nodes staging Neural Network.

Learning Techniques

Hyper Parameter Tuning
Figure 3.1 IDEF0 for breast lymph nodes gene biomarker classification.
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Figure 3.2 illustrates the detailed IDEF0, showing the steps of the model creation, starting with the
data mining step progressing through the data labeling, feature selection, data preprocessing, and
finally, the supervised classification.

Figure 3.2 Detailed IDEF0 for breast lymph nodes gene biomarker classification.
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3.2 Classification Model Progress and Evaluation steps
The dataset that is used in this model contains 1,904 samples with 24,368 gene expression per
sample. The dataset is a high-dimensional multi-class dataset, and classifying it would be a
challenge in the field of machine learning. Thus, feature selection is fundamental to limit the
number of genes to the essential (active) genes. At this point, the dataset is ready for classification.
The candidate models for the classification are SVM, Bayes Nets, Random Forest, Decision Tree,
and ANN-Deep Learning.

As illustrated in Figure 3.3 below, the candidate classification models progress through model
evaluation steps, including Cross-validation, evaluating performance on both variance and bias,
and finally test the measure performance.

Figure 3.3 A schematic view of the proposed workflow for predicting the breast cancer lymph nodes stage throughout preprocessing
and prediction steps.
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Figure 3.3 illustrates the workflow we utilized in order to develop the machine learning model to
identify gene biomarkers for breast cancer lymph nodes metastasis. The flow starts by defining the
objective. The objective is to increase the model F1-Score, accuracy, sensitivity, and specificity,
as well as maximizing the correctly classified instances and minimize the incorrectly classified
instances. Once the objectives have been identified, the data is preprocessed, where the genomics
data and clinical dosimetry data are filtered and infused together, followed by data split in which
data is split into training, validation, and testing data.

3.3 Genomics and Data Labeling
The METABRIC dataset is the source of data in this research. The data set is publicly accessible
through the cBioPortal for cancer genomics (http://cbioportal.org). METABRIC dataset is one of
the Multidimensional cancer genomics datasets that is available on the portal (Gao et al., 2013).
The dataset contains 2,510 samples of breast patients, out of which 1,905 have a lymphedema
status/stage. The dataset is categorized into two main subsets. The first subset is composed of 33
clinical attributes such as age, tumor size, treatment type, lymph nodes status. The second subset
is composed of 24,371 genetics attributes.

This research focuses on the lymphedema nodes status/Stage and analyzing the corresponding
gene expression. Patients with lymphedema are labeled by five stages, which are adopted from the
American joint committee on Cancer (AJCC) materials (Ferrucci Jr et al., 1980). Table 1. Stage
NX was excluded from the analysis due to the inability to assess the nodes. The number of samples
per class is represented in Table 3.1. feature selection approach was performed on the data set as
a preprocessing step for multiple reasons, including i) enable the machine learning algorithm to
train faster, ii) avoid overfitting, and iii) improve the accuracy of the model by using the specific
subset of active genes.
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Table 3.1 American joint committee on cancer materials pathologic lymph node status.

Lymph node Stage

Lymph node status

NX

Lymph nodes cannot be assessed.

N0

Lymph nodes do not have cancer

N1

1 to 3 lymph nodes do have cancer

N2

4 to 9 lymph nodes do have cancer

N3

Ten or more lymph nodes do have cancer

3.4 Data Preprocessing

3.4.1 Class imbalance
As shown in the class distribution below Figure 3.4, the data set is imbalanced in which the
majority class, N0, represents 52% of the dataset, while the minority class represents 48%, with
N3 only representing 5%. In this case, we have a severe imbalance in which the distribution of N3
is uneven by a large amount in the training dataset.

Imbalanced classifications present a problem for predictive modeling. As most of the machine
learning algorithms used for classification were built around the assumption of an equal number
of instances for each class, this results in creating models, especially for the minority class, that
have low predictive efficiency. Hence, we applied the accompanying strategies to deal with this
issue.
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Minority Class N3
5%

CLASS DISTRIBUTION

Minority Class N2
11%

Majority Class N0
52%
Minority Class N1
32%

Figure 3.4 Class distribution.

3.4.2 Random over-sampling and resampling

There are serval methods to handle the class imbalance problem. These models are categorized as
random oversampling, resampling, and random under-sampling. In this model, two methods were
used, Cost-sensitive classifier and random over-sampling are utilized to make the class distribution
balanced through random replication of the minority class samples. The synthetic minority oversampling technique (SMOTE) was utilized as the synthetic data generators for the minority classes.
SMOTE improves the sensitivity of predicting the minority class by creating “feature space” for
the minority class, in which it generates a new sample from the k nearest neighbors (Chang and
Lin, 2011). For example, SMOTE first selects a minority class instance at random and finds its k
nearest minority class neighbors. The synthetic instance is then created by choosing one of the k
nearest neighbors at random and connecting a line segment in the feature space. This method was
utilized as shown in Figure 3.5 to avoid discarding potentially useful data that could be important
for the learning process, which is the main drawback of randomly under-sampling (Ali and Feng,
2016).
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Figure 3.5 Oversampling using SMOTE.

3.4.3 Using a cost-Sensitive classifier.

The second method that was used in addition to SMOTE that was used earlier to avoid class
imbalance was a Cost-Sensitive classifier in the Weka machine learning tool was used in order to
avoid any inclinations in the model towards minority class. This is evident when using any of the
penalizing models that apply extra weight to minority classes. Cost-sensitive learning aims to
minimize the cost of the model on a training dataset, in which the cost represents the penalty of an
incorrect prediction (Mucaki et al., 2016).

3.4.4

Instances normalization

Instances were normalized before classifying to improve and optimize the machine learning
(Santurkar et al., 2018). Instance’s normalization improves machine learning by multiple factors
such as reducing internal covariate shift, which changes the distribution of the network activations
allowing for improvement in the training. Normalization allows for faster optimization as it
restricts them to a certain range (Ulyanov et al., 2016).
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3.5 Feature Selection
Feature selection is a process of selecting features that have the highest contribution to the target
or prediction variable. It is one of the fundamental notions of machine learning that has a
significant impact on the learning model's performance. Irrelevant features in the dataset reduce
the models' accuracy, restrict the machine learning algorithm to train fast, increase model
complexity and makes it harder to interpret, and finally may lead to overfitting (Alshamlan et al.,
2015). In addition to eliminating irrelevant features, the cancer genomics dataset used in this
research is a Multidimensional dataset that suffers from the curse of dimensionality, a restricted
number of samples, and noise genes, which increases the need of utilizing feature selection
techniques (Alshamlan et al., 2013, Guo et al., 2006).

There are three main types of feature selection techniques that are commonly used. First is the
filter methods such as Chi-Square, Pearson correlation, Linear discriminant analysis, ANOVA,
and variance thresholding. Filter methods select features based on their scores in various statistical
tests for their correlation with the Target variable, Advantages of filter methods are that they have
a low computation time, independent of the learning classifier, and do not overfit the data.
However, the disadvantage of the filter method is that they ignore any interactions or correlations
between features. The second method is the Wrapper methods such as forward selection, backward
selection, and Recursive feature selection. The Wrapper method selects a random subset of features
and trains the model using a learning algorithm, and evaluates the importance of each feature of
the randomly chosen subset and based on the performance, the model iterates and select a different
subset of features until the optimal subset is reached, Figure 3.6 illustrates how wrapper feature
selection is performed. One of the main Advantages of the wrapper methods is that it takes into
consideration the model feature dependencies when evaluating the features. However, the two
main disadvantages of the wrapper method are the risk of overfitting and the fact it requires high
computational intensity (Chandrashekar and Sahin, 2014).

In this research, I used a hybrid model between the two methods, the filter method, and the wrapper
method, by doing that, I was able to avoid the drawbacks that each method encompasses. For
example, I used the filter method to narrow the number of features using the statistical analysis
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Chi-Square, and with that, I avoided the high computation time as well as the overfitting that would
have taken place if I used the wrapper method on the original dataset.

Figure 3.6 Wrapper feature selection using RFE and Random Forest.

3.5.1 Filter feature selection - chi-square

As stated earlier, our dataset contains 24,371 genetic attributes. In this research, Chi-Square was
selected to be the statistical correlation test applied to the 24,371 genetic attributes. The Chi-Square
statistic test is non-parametric, robust, and has low computation usage. In addition to that, it was
the optimal choice due to the fact that the Chi-Square test does not require equality of variances
among the homoscedasticity of the data (McHugh, 2013).

The Chi-Square test is used in statistics to test the independence of two events by calculating Chisquare between each feature and the target (Class) and select the desired number of features with
the best Chi-Square scores Equation 3.1. Using the Chi-square test, we were able to select the top
200 highest correlated features for the total 24,371 genetic attributes.
(𝑂𝑖𝑗 − 𝐸𝑖𝑗 )2
𝑥 = ∑(
𝐸𝑖𝑗
2

(3.1)

𝑖 ,𝑗
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3.5.2 Wrapper feature selection - recursive feature elimination

Recursive feature elimination (RFE) was the selected wrapper feature selection algorithm in this
research due to it is simplicity in configuring and usage, as well as it is effective in selecting
features in the dataset that are most relevant in predicting the target variable. RFE functions
through searching for a subset of features starting with the complete set of features in the dataset
and effectively removing features until the subset yielding the highest performance remains. The
highest performance is evaluated and achieved through a machine learning algorithm in the core
of the model. In this research, the machine learning algorithm used is fitting and refitting the model
until the desired performance is achieved is Random Forest.

As illustrated in Figure 3.6, the RFE was applied on the top 200 features that were the output of
the filter feature selection, followed by fitting the subset using Random Forest and gauging the
model until the desired performance is achieved.

Figure 3.7 below illustrates the Recursive Feature elimination results. On the y-axis is the
percentage of accurately classified (accuracy) and on the x-axis is the number of features in the
data set. As shown, we start off with all the 200 features and fitting the machine learning algorithm,
Random Forest. The result shows an accuracy of approximately 91%, then the model starts the
elimination of features and refitting the model. Based on the results, the optimal number of features
that yield the highest accuracy is 168 features which correspond to a yield accuracy of 93%.

The accuracy of 93% is considered an acceptable level. The only drawback is that the number of
features yields that accuracy is high. One hundred sixty-eight features are considered significantly
high according to biologists and industry leaders such as illummnia (Barbosa-Morais et al., 2010),
as well as sampling this high number of genetic attributes will defeat one of the main objectives
of this research which is genetic classification in a timely manner. Using the output of the RFE,
the target number of features that will be used moving forward is the top 20 features. As illustrated
below, the top 20 subset features yield an approximate accuracy of 88%.
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168 Features is
Optimal, With ~ 93%
accuracy.

20 Features is Target, with ~88%
accuracy.

Figure 3.7 Recursive Feature Elimination Results.
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CHAPTER 4: FEATURE ANALYSIS
Understanding and analyzing the top 20 selected features is a critical step before proceeding in
building the machine learning model. Analyzing the features gives insights such as which type of
algorithm is most optimal with potential high performance as well as areas to focus on in order to
avoid overfitting. Figure 4.1 illustrated the genetic feature’s collinearity through a heatmap,
modeling the gene-gene interaction helps understand the underlying data. Feature collinearity
occurs when two or more independent variables are highly correlated with one another in a
regression model, which could lead to that an independent variable can be predicted from another
independent variable. From the heatmap, it is concluded that the majority of the 20 features do not
have any collinearity except for two genes (CD19 and DKFZp686O16217).

Figure 4.1 Genetic features collinearity.
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The second area of focus is how the genetic features correlate within each class. Figures 4.2 and
4.3 illustrate the relationship between the genetic feature and each of the classes. With a detailed
analysis of the heatmap, it could be included that the genetic features have similar collinearity with
respect to N1 and N0 classes. This is important information as we build the learning algorithm in
which the model could potentially misclassify between N0 and N1, which would require special
attention while building the model.

Figure 4.2 Genetic features collinearity with respect to N0 and N1 Class, respectively.

Figure 4.3 Genetic features collinearity with respect to N2 and N3 class, respectively.
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Moreover, based on the heat map gene to gene collinearity and the feature collinearity with respect
to each class, we conclude a deep dive is required to calculate the interactions of a list of genes of
concern. This is accomplished through a Venn diagram in Figure 4.4. After a detailed review of
the Venn diagram, we can conclude that the genes of collinearity concern will have a minimal to
neglectable effect on the machine learning model.

Figure 4.4 Venn Diagram showing the interaction of genes of concern.

Finally, as an example, the boxplots in Figure 4.5 are used to analyze the relationship between the
genetic biomarkers and each of the classes. From observing the range and distribution of each
genetic biomarker and respected class, it concluded that genetic biomarkers distribution overlaps
to a great extent between classes which will require extensive training in order to train the machine
learning model to correctly predict the true classes. It is also observed that there is a greater
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variability across classes as well as the larger number of outliers. Finally, we can conclude that
with 95% confidence, that the true medians do differ.

Figure 4.5 Boxplot of genetic variation with respect to class.
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CHAPTER 5: LEARNING TECHNIQUES
Machine learning techniques have and continue to be one of the great focuses of research, which
leads to consistent development of learning techniques, including the introduction of new methods.
In this research and based on the literature review, several learning techniques have been tested,
which include, Support Victor Machine, Naïve Bayes classifier, decision trees, and finally,
artificial neural networks. These learning techniques have been chosen due to their optimal fit to
the type of data, structure, and size of the dataset used and the desired outcome. Figure 5.1
illustrates a schematic of how data flow progress through the model build. First, the data with the
top 20 features are uploaded then the data gets partitioned into training and validation datasets (a
test dataset is never introduced to avoid any chance of model learning). Once the data is partitioned,
the training dataset is used in the algorithm learner. Once the algorithm is trained, the validation
data is introduced to the algorithm predictor. Finally, the validation results are pushed to the scorer,
in which performance is recorded and evaluated.

Figure 5.1 Classification data flow by KNIME.
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5.1 Support Vector Machine
Support Vector Machine is a computational supervised learning method based on the statistical
learning theory developed by Vapnik, and it has great capacity in processing extremely sizeable
feature spaces (Widodo and Yang, 2007). SVM has been broadly recognized as a consistent
classifier. It is commonly applied to integrate various types of kernels to implicitly move data into
a higher dimension where the data points are more disconnected. The concept behind implicitly
transferring data into a higher dimension using dot products is to avoid the use of costly
transferring functions (Liu et al., 2018).
SVM constructs the best hyperplane 𝑓(𝑥)=0 within the datasets by splitting and solving a
constrained quadratic optimization problem established on the structural risk minimization (SRM)
(Schölkopf et al., 2002).
𝑁

𝑦 = 𝑓(𝑥) = 𝑊 𝑇 + 𝑏 = ∑ 𝑊𝑖 𝑥𝑖 + 𝑏

(5.1)

𝑖=1

Where 𝑊 is an N-dimensional vector and b is a scalar. As illustrated in Figure 5.2, the vector w
and scalar b are used to identify the position of splitting the hyperplane. The decision function is
made using sign f(x) to create a separating hyperplane that classifies input data in either positive
Class or negative Class.

Figure 5.2 Hyperplane for binary classification by SVM (Adankon and Cheriet, 2009).
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5.2 Naïve Bayes Classifier
Naïve Bayes a classification technique based on Bayes’ Theorem with a notion of independence
among predictors. Naive Bayes classifier presumes that the occurrence of a particular feature in a
class is irrelevant to the presence of any other feature. Naive Bayes model is simple to develop
and useful when it comes to extremely significant data sets (Rish, 2001).

(5.2)

where,
P (Y| X) is the posterior probability of class (Y, target) given predictor (X, attributes).
P(Y) is the prior probability of class.
P(X|Y) is the likelihood which is the probability of the predictor given class.
P(X) is the prior probability of the predictor.

5.3 Decision Trees
Decision trees are considered to be one of the most popular approaches for representing classifiers
due to their simplicity. Decision trees consist of nodes, which is the test of a certain attribute
followed by branches, which corresponds to the outcome of the test, and finally, the leaf nodes,
which represent the predicted outcome.

Decision trees are supervised machine learning techniques where the data is constantly broken
down in a top-down fashion into subsets in accordance with a certain parameter. There are two
main types of decision tree builds first is classification, and the second is regression models. Since
our data is continuous data, the decision tree regression model is utilized (Rokach and Maimon,
2005). The fundamental algorithm for building decision trees called ID3 by J. R. Quinlan employs
a top-down, greedy search through the space of possible branches with no backtracking. ID3 uses
Entropy and Information Gain to construct a decision tree (Quinlan, 1986).
Random Forest classifier consists of a large number of individual decision trees that operate as an
ensemble. Each individual tree in the Random Forest outputs a class prediction, then the classes
across each individual decision tree are evaluated, and the prediction with the most votes becomes
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the final model prediction (Rodriguez-Galiano et al., 2012). Illustrated in Figure 5.3, the top main
nodes and branches of the decision tree model and, as shown, classes are evaluated and tested at
each of the nodes, and classification percentage is recorded.
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Figure 5.3 Top main portion of the Decision Tree Classification.
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5.4 Artificial Neural Networks (Deep Learning)
The objective of an Artificial neural network is to learn how to map input data to output classes
(Bengio et al., 2017). Artificial Neural Networks are effective data-guided modeling tools
commonly used for nonlinear structures dynamic modeling due to their comprehensive capabilities
and flexible configuration that allow capturing convoluted nonlinear activities(Anderson, 1995).
In this research, the Feed-forward multi-layer perceptron ANNs type is utilized, which is one of
the most frequently in engineering applications (Svozil et al., 1997). A feed-forward network
defines a mapping and learns the value of the parameters that result in the best function
approximation (Bengio et al., 2017).
ANN architecture is based on the structure and function of the biological neural network. Neural
networks are built of simple elements called neurons, which take in a real value, multiply it by
weight, and run it through a nonlinear activation function, Equation 5.3 (Kröse et al., 1993).
𝑛

𝑦 = 𝑓(∑ 𝑋𝑖 𝑊𝑖 + 𝑏)

(5.3)

𝑖=1

The first layer consists of input neurons to receive the external data in order to perform pattern
recognition. The first layer neurons send data on to the deeper layers, which in turn will send the
final output data to the last output layer, which gives the problem solution. Each layer acts both as
an input and output layer that allows the model to understand more complex objects. The layers
are connected through acyclic arcs (Svozil et al., 1997).

Figure 5.4 illustrates the initial neural network. As shown, the network is initiated input layer
consisting of 20 input neurons. Each neuron represents one of the 20 genetic biomarkers, the output
layer consists of 4 output neurons, and each neuron represents a class. In between the input layer
and output, the layer is the hidden layers, the configuration of the hidden layer is based on the
capability of finding the optimal number of layers and number of nodes in each of the layers,
finding the optimal activation function, and finally defining the learning rate and number of
Epochs.
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THE BLACK BOX

Figure 5.4 The Initial Artificial Neural Network.

5.4.1 Hyperparameter tuning

Hyperparameters are the variables that define the network structure and the variables which
establish how the network is trained. Tuning these parameters yields to higher performance of the
ANN. The parameters are weight initialization, network capacity, activation function, learning
rate, and momentum. Training and tuning a deep learning neural network model using stochastic
gradient descent with back-propagation involves choosing and optimizing a number of
hyperparameters.

Finding parameters for many ANN entails solving a convex or a non-convex optimization
problem, that is, an error surface. In this work, we are dealing with a non-convex problem. The
algorithm that is commonly applied to configure the error surface is called stochastic gradient
descent (SGD) (Bengio et al., 2017).

Stochastic gradient descent is effective as it utilizes the gradient information specifically to update
the model weights through an algorithm called back-propagation. Back-propagation defines a
technique to evaluate the derivatives of the network training error with respect to the weights by a
clever application of the derivative chain rule (Reed and MarksII, 1999).
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Weight initialization
Weight initialization is a technique to set the weights of a neural network to small random values
that identify the beginning point for the optimization of the neural network model. There are many
approaches for weight initialization. The techniques are driven by the type of activation function.
As will discover later in this research, the optimal activation function for the multi-layer Perceptron
model is a rectified linear (ReLU) activation function. The current standard method for
initialization of the weights of neural network layers that use the rectified linear (ReLU) activation
function is called “he” initialization, which is named after “Kaiming He” (He et al., 2015). Below
is the equation that is used to calculate the He weight, where Gaussian probability distribution (G)
with a mean of 0.0 and a standard deviation of sqrt(2/n), where n is the number of inputs to the
node.

weight = G (0.0, sqrt(2/n))

(5.4)

Figure 5.5 illustrates the spread of “he” weight initialization. With Inputs from One to One
Hundred, it is evident that with few inputs, the range is large, approximately -1.5 and 1.5, and this
spread drops to approximately -0.1 and 0.1 as the number of inputs increase.

Figure 5.5 Plot of range of “He” weight initialization with inputs from one to one hundred.
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After calculating the weights for our model with 20 inputs to the node, the calculated standard
deviation of the weights is about 0.316228, the range of the weights is about -1.034 to 0.946. and
finally, the mean of the generated weights is approximately 0.005.

Neural network model capacity
The second is defining the capacity of a neural network. The capacity of a network implies the
range of the types of functions that the model can approximate. The capacity can be controlled by
two characteristics of the model. First, the Number of Nodes referred to as width, and second is
the number of layers referred to as depth. The capacity controls whether the model is more likely
to overfit or underfit by altering its capacity. (Bengio et al., 2017). Having depth in training deep
models, e.g., those with many hidden layers, can be computationally more efficient than training
a single-layer network with a vast number of nodes.

Typically, it is not feasible to analytically calculate the number of layers and the number of nodes
to apply per layer in the neural network to address a classification modeling problem (Reed and
MarksII, 1999). The number of layers and the number of nodes in each layer are model parameter
inputs that have to be specified prior to running the model. There are multiple methods in
configuring the capacity of the hidden layers, and in building my neural network, I used the below
two approaches.

1. Automated Search: used an automated search to test different random and directed
(Bayesian optimization) network configurations and calculated the performance for each
configuration.
2. Depth: as suggested in the deep learning textbook by Goodfellow, that using deep
architectures does certainly convey a useful prior over the space of functions the model
learns (Bengio et al., 2017). In other words, networks with many layers may be a heuristic
approach to configuring networks for challenging predictive modeling problems.
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The neural network activation function
The activation function in a neural network describes in what manner the weighted sum of the
input is converted into an output from the nodes in a layer of the neural network (Leshno et al.,
1993). The selection of the optimal activation function has a direct impact on the performance of
the neural network (Lin et al., 2013). There are three main activation functions commonly used for
the hidden layers, rectified linear activation (ReLU), logistic (sigmoid), or hyperbolic tangent
(Tanh) (Chollet, 2018). Figure 5.6 illustrates the process flow for choosing the optimal activation
function for the hidden layers and the output layer. Three activation functions have been selected
and used in the neural network build, ReLU and LeakyRelu for all the hidden layers and Softmax
for the output layer.

Hidden or
Output layer?

Hidden Layer

Output Layer

Network Type

Type of model

Multilayer
preceptron

CNN

ReLU
Activation

ReLU
Activation

Recurrent
Neural Net

Sigmoid
activation

Classification

Tanh
Activation

Regression

Binary

Multi-Class

Multi-label

Sigmoid
Activation

Softmax
activation

Sigmoid

Linear
Activation

Figure 5.6 Activation function selection flow chart.

Equation 5.5 illustrates how the ReLU function is calculated.
y = max (0.0, x)

(5.5)

Where if the input value (x) is negative, then a value of 0.0 is returned. Otherwise, the calculated
value is returned. The function is linear for values greater than zero, indicating it behaves as a
linear activation function when training a neural network using back-propagation. However, it is
a nonlinear function as negative values are always output as zero Figure 5.7 (Glorot et al., 2011).
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Leaky ReLU Figure 5.8 is a derivative of the ReLU function that allows slight negative values
when the input is less than zero(Maas et al., 2013).

Figure 5.7 Plot of Inputs vs. Outputs for the ReLU activation function

Figure 5.8 Plot of Inputs vs. Outputs for the Leaky ReLU activation function (Maas et al., 2013)

Since the model output layer is a multi-class classification problem, a SoftMax function has been
utilized (Goodfellow et al., 2016). The term softmax is applied since this activation function
signifies a soft version of the winner-takes-all activation model in which the unit with the largest
input has output +1 while all other units have output 0 (Bishop, 1995). Below is the equation for
the softmax function, where z is the vector of inputs to the output layer and j indexes the output
units from 1,2,3…k.
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𝑒 𝑧𝑗
𝜎 (𝑧)𝑗 = 𝐾
∑𝑘=1 𝑒 𝑧𝑘

(5.6)

Neural network learning rate and momentum

The learning rate regulates how rapidly the model is fitted to the problem. Smaller learning rates
need more training epochs (specifies the number of times that the learning algorithm will work
through the complete training dataset) given the smaller changes made to the weights of each
update, whereas larger learning rates consequence in fast changes and require fewer training
epochs. The default learning rate is 0.01, and no momentum is used by default. A learning rate that
is too big can lead the network to converge too quickly to a suboptimal result, while a learning rate
that is too little can cause the network to get stuck Figure 5.9 (Goodfellow et al., 2016).

Figure 5.9 Learning rate Optimal behaviors. (JORDAN, 2018).

In our model, multiple optimizers were examined through an algorithm that compares the
optimizers with respect to the performance while fixing all other parameters. As shown in Figure
25, the optimizer “Adam” (Kingma and Ba, 2014) scored the highest.

Figure 5.10 Optimal Optimizer comparison.
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The optimizer “Adam” strives to find the global minimum point instead of the local minimum
point. It works by combining the advantages of adaptive learning rate as well as root mean square
propagation where the performance of the network on the training dataset can be observed by the
learning algorithm, and the learning rate can be altered in response (Kingma and Ba, 2014). This
is implemented by making the learning rate reduced once the performance of the model plateaus
(Goodfellow et al., 2016). Adaptive learning rate methods are beneficial and commonly used. A
good adaptive algorithm will usually converge more rapidly than plain back-propagation with an
inadequately chosen fixed learning rate (Reed and MarksII, 1999). Root Mean Square Propagation
functions by maintaining per-parameter learning rates that are adapted based on the average of
recent degrees of the gradients for the weight, in other words, how quickly it can change (Kingma
and Ba, 2014).
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CHAPTER 6: RESULTS
In this study, we primarily applied four classification approaches in the first stage individually,
which were support vector machines, decision trees, Random Forest, and Naïve Bayes. Then, we
enhanced by undergoing a step further to utilize the multi-class classification method using a deep
neural network.

6.1 Performance Measures
In addition to the accuracy performance measure, Equation 6.1, other performance parameters
were utilized to gauge and truly evaluate the performance of Decision trees, Classifiers, Statistical
Models, and the Artificial neuron network. The other performance parameters included Sensitivity
(Recall), Specificity, Precision, and Finally F-score, Equations 6.2 through 6.5.

Sensitivity (Recall) =

Specificity =

𝑇𝑃
𝑇𝑃 + 𝐹𝑁
𝑇𝑁

𝑇𝑁+𝐹𝑃

(6.1)

(6.2)

where,
TP represents the number of true positives.
FN represents the number of misclassified negatives.
FP represents the number of misclassified positives.
TN represents the number of true negatives.

Accuracy =

F-measure =

𝑤ℎ𝑒𝑟𝑒,

𝑇𝑃+𝑇𝑁
𝑇𝑃+𝐹𝑁+𝐹𝑃+𝑇𝑁

2 𝑋 𝑃𝑃𝑉 𝑋 𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦
𝑃𝑃𝑉+𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦

PPV =

𝑇𝑃
𝑇𝑃+𝐹𝑃

(6.3)

(6.4)

(6.5)
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6.2 Decision Trees and Statistical Models Classifiers Results
Figure 6.1 through 6.3 illustrates the Accuracy, Recall, and F-measure performance of the Random
Forest classifier, decision tree classifier, and the statistical models SVM and Naïve Bayes. It can
be observed that decision trees and in specific Random Forest classifier outperformance all other
algorithms with an accuracy of ~88%.

Figure 6.1 Classifier’s accuracy performance results.
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Figure 6.2 Classifier’s recall results.
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Figure 6.3 Classifier's F-measure results.
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A confusion matrix is a way of visualizing the performance of the machine learning model
prediction. Every box in a confusion matrix indicates the number of predictions made by the ML
model where it classified the classes correctly or incorrectly.
Taking a deep dive in our highest performing classifier Random Forest’s confusion matrix in
Tables 6.1. We can conclude that the main reason for misclassification takes place within classes
N0 and N1, in which the Random Forest model is inappropriately predicting the wrong N0 and N1
Class. This can be improved by step classification, where Random Forest classification would be
performed in a step format, first step multiclassification for the classes N2, N3, and Rest
(Combining N0 and N1) followed by binary classification between N0 and N1. This procedure
would help increase the accuracy, but it has drawbacks, including overfitting.

Table 6.1 Random Forest confusion matrix.

The results of the classical machine learning tools used did not meet an acceptable performance
level, and to avoid enhancing the tools by introducing mechanisms, such as step-classification or
one–verses–rest hierarchy models that potentially could jeopardize the model functionality by
causing overfitting. Developing a multi-class neural network would be the optimal solution to
drive higher performance.

6.3 Artificial Neural Network Results
In section 5.4.1 it was discussed the methods used in the study to evaluate the neural network
parameters and selecting the optimal parameters in building the neural network.
Figure 6.4 demonstrates the entire neural network, with the 20 genetic biomarkers as the input
nodes to the neural network and the four-class as the network output.
For the capacity parameters, which includes the number of hidden layers and number of nodes per
hidden layer, the optimal results after using the auto search and depth approaches are a total of 5
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layers, with 64 nodes for the first hidden layer followed by 128 nodes for the second and third
hidden layer, and finally 64 nodes for the fourth and fifth hidden layer. Each of these layers was
assigned a “ReLU” activation function, except for the fourth layer, a “LeakyReLU” was used to
allow for slight negative values when the input is less than zero as well as the output layer a
SoftMax activation function was used.

Figure 6.4 The full neural network, showing the depth and width of the network.

Figures 6.5, 6.6, and 6.7 demonstrate the neural network accuracy, AUC, and Lose results. The Xaxis is the number of training epochs, in other words, how this metric evolves over time, and the
Y-axis is the value of the specific metric. For each plot, the solid line shows the metric averaged
over the number of k-folds, and the shaded region is the mean value +/- 1 standard deviation. The
red curves are for the training data, and the blue curves are for the validation data. The text in each
is the final value of the metric for the training or (validation) data, respectively.
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Figure 30 is the accuracy matrix which is the fraction of data that is correctly labeled over the total
number of data (higher is better). Our model shows an accuracy of 96% with slight mean values.

Figure 6.5 Neural network accuracy chart.

The area under the curve (AUC) is a critical measurement for model performance, which signifies
the probability that the neural network will rank a randomly chosen positive instance higher than
a randomly chosen negative one. The area under the curve is typically used to measure the
relationship between precision and recall and the performance of a classifier. A large area
represents both high precision and high recall.
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The approximate AUC (area under the ROC curve) was computed via Riemann sum Figure 31.
The ROC (receiver operating characteristic) curve is a graph of the true positive rate vs. the false
positive rate. That is, it shows the number of positive labels over the sum of positive labels and
labels that were falsely labeled negative (i.e., number of N0 data points that were labeled N0
divided by the number of N0 data points that were labeled N0 plus those that were labeled as
something else). The false-positive rate is the inverse of this. Having a larger AUC value means
that we have a better ratio of true positives to false positives. The AUC value is 97% which is
averaged across each class (N0, N1, N2, and N3).

Figure 6.6 AUC Chart.

Figure 32 illustrates the loss function results; in its core, the loss function maps decisions to their
associated costs. The final purpose of any machine learning model depends on minimizing or
maximizing a function that is called “objective function”. The set of functions that are targeted to
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be minimized are called “loss functions”. The loss function is used as a measurement of how good
a prediction model does in terms of being able to predict the expected outcome.
The total "error" in our model based on our optimization function "categorical cross-entropy" is
24%. This value is computed via.
𝑁

𝐶

𝐿 = − ∑ ∑ 𝑦𝑖,𝑗 log(𝑦′𝑖,𝑗 )

(6.6)

𝑖=0 𝑗=0

Where N is the number of data points, C is the number of classes, yi,j is a binary indicator that
the true label for point i is class j , and y’i,j is the predicted probability that point i is class j .
Our machine learning model seeks to minimize this function.

Figure 6.7 Neural network loss chart.
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Figure 6.8 is the normalized confusion matrix, and we can conclude that the neural network overall
performance very well, especially in predicting the classes N2 and N3 approximately 100% with
some error when it comes to predicting N0 and N1.

Figure 6.8 Neural Network Confusion Matrix.

Finally, as mentioned earlier in chapter 5, the dataset was split into three partitions, learning
dataset, validation dataset, and finally, test dataset. The test data set was never introduced to the
model in any of the training or validation processes to memic, real data inputs and evaluate the test
performance. The model showed high performance when the test data portion was introduced,
scoring accuracy of 87% and AUC of 91%, Figure 6.9.
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Figure 6.9 Test dataset accuracy and AUC results.
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CHAPTER 7: CONCLUSION
7.1 Overview
In this chapter, I will portray the novelties and contributions of the research, as well as the
significance and benefits of the research. Following that, I will highlight areas of enhancements
and opportunities for future work, and finally, the conclusion will be discussed.

7.2 Novelties and Contribution
To the best of our knowledge, this is the first machine learning model in the bioinformatics domain
that can predict the likelihood of breast lymph node metastasis as well as the stage/status lymph
node metastasis based on gene biomarkers.
•

The machine learning model was developed based on feature-selected 20 gene biomarkers,
and the selection process included a hybrid combination of feature filtering using ChiSquare and a wrapper feature selection, recursive feature elimination.

•

In preparing the learning dataset and avoiding the curse of dimensionality, different
techniques were introduced to handle the dataset.

•

A standard learning technique was applied to the 20 feature-selected gene biomarkers that
included SVM, Random Forest, decision tree, and naïve Bayes classifiers. The standard
classifiers showed promising results, but due to the complexity of the multi-class model,
the standard classifiers showed mid-range performance. Performance results are discussed
with further details in chapter 6.

•

An artificial Neural network was developed to address the classification problem. The
novelty of this unique model has never been introduced in the literature, to the best of our
knowledge.

•

The Neural network parameters, such as weight initialization, model capacity, activation
function, and finally learning rate and momentum, were tuned using a combination of
hyperparameter tuning.

•

The Artificial neural network model showed high performance, outperforming the standard
classifiers.
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•

The deep learning model results were analyzed using multiple performance measures,
including sensitivity, specificity, loss, AUC, and F-measure, discussed in further detail in
chapter 6.

7.3 Research Significance and Benefits
According to the Canadian cancer society, in the past years, different types of cancer were grouped
based on which organ in the patient’s body where cancer first starts to develop as well as the shape
of cancer under a microscope (Canadian Cancer Society, 2021). Recently this has changed. As
studies have developed in the human genome arena, cancer is now being grouped based on gene
mutations. This change in cancer identification will assist the providers in improving the diagnosis
and prognosis of cancer patients and how appropriately a treatment is likely to work.
It is apparent that the incorporation of multidimensional heterogeneous genetic data, fused with
the application of various techniques for feature selection and model classification, would offer
encouraging tools for inference in the cancer domain.
Using genes as biomarkers will definitely help in the prognosis and diagnosis of cancer. In the
presented work, the 20 identified genes would serve as biomarkers for Breast lymph node
metastasis, and the developed supervised neural network would serve as a decision tool in
predicting the likelihood of a breast cancer patient developing lymph node metastasis as well as
the stage/status of the lymph node metastasis.
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7.4 Limitations
One of the most common limitations in any machine learning model is the size of the data sample.
An appropriately large dataset is a basic requirement in any classification modeling, a dataset that
allows for adequate splitting into training, validation, and testing sets, which in turn would lead to
sensible validation of the model. A rich set of patients used for their lymph node staging prediction
can enhance the generalizability of the predictive model. In the presented work, a midsized dataset
has been utilized.
One of the drawbacks of the proposed model is not accompanying the technical validation with a
medical validation process. A collaboration team from the medical, pathology, pharmaceutical,
biological domains would add significant value to the model validation phase, in which data would
be gathered from, first the breast lymph node tissue status/stage data, and Second the
corresponding data of the proposed 20 gene biomarkers by undergoing wet-lab experiments to
study the relevancy with the breast lymph node metastasis.

7.5 Recommendations
Medical, pharmaceutical, biological validation would definitely enhance and increase the overall
quality of the neural network model, as well as the generalizability and reproducibility of the
predictive classifier.
In the presented work, I have built a neural network to address the classification model, given the
flexibility and robustness of neural networks as predictive models, and the model that paves the
way for further research in exploring the applicability of other classification techniques, such as
linear regression methods.
Finally, the methodology presented in this work provides the groundwork for expanding into other
areas of cancer, in which identifying biomarkers as well as developing a classification model is
critical.
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7.6 Summary
This study presented an analysis of prognostic factors of breast cancer lymph node metastasis using
machine learning techniques. The METABRIC breast cancer data set was analyzed in order to
predict the likelihood of a breast cancer patient developing lymph node metastasis as well as
predict the stage/status of the lymph node metastasis. A hybrid feature selection technique was
developed, and twenty gene biomarkers were proposed as candidate genes for successful
classifications.
The model initially was evaluated across multiple standard algorithms that include SVM, Naïve
Bayes, decision trees, and Random Forest. The Random Forest algorithm yielded better accuracy
when compared to other algorithms but still did not meet the performance targets initially set,
especially when the number of genes was limited to only the 20 gene biomarkers. An artificial
neural network was developed, and the parameters were configured using hyperparameters tuning
techniques. The neural network outperformed on all the performance measures, scoring accuracy
of 96% for training partition and 85% for both test and validation partitions. As far as the area
under the curve (AUC), the neural network scored 100% for the training dataset, 95% for the
validation, and finally 90% for the test dataset. For the total “error” for our model (lose), the model
scored 24%.

7.7 Conclusion
This research finds sets of biomarkers genes that can predict the outcomes of cancer spread among
the axillary lymph nodes. The supervised machine learning model is built based on the gene’s
expression profiles for breast cancer cohort of patients with different lymph nodes stages. We
evaluated the model using serval algorithms and concluded that Artificial Neural Network yields
the highest performance.
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APPENDICES
Appendix A: Sample of Patients Gene expression and clinical data
Approximately 25,000 gene expression which includes approximately 60,000,000 gene expression
values for 2,510 clinical trial patients.
Table 2 Sample of the patient's clinical data.

Clinical Data
Lymph nodes
examined
positive

Overall
Survival
Status

….

Tumor
Stage

Patient's
Vital Status

Patient ID

Age at Diagnosis

Type of Breast
Surgery

MB-0000

75.65

MASTECTOMY

10

0:LIVING

….

2

Living

MB-0002

43.19

BREAST
CONSERVING

0

0:LIVING

….

1

Living

MB-0005

48.87

MASTECTOMY

1

1:DECEASED

….

2

Died of
Disease

MB-0006

47.68

MASTECTOMY

3

0:LIVING

….

2

Living

MB-0008

76.97

MASTECTOMY

8

1:DECEASED

….

2

MB-0010

78.77

MASTECTOMY

0

1:DECEASED

….

4

MB-0014

56.45

BREAST
CONSERVING

1

0:LIVING

….

2

MB-0020

70

MASTECTOMY

NA

1:DECEASED

….

3

MB-0022

89.08

BREAST
CONSERVING

1

1:DECEASED

….

2

….

….

….

….

…..

….

….

Died of
Disease
Died of
Disease
Living
Died of
Disease
Died of Other
Causes
….
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Table 3 Sample of the patient's genes expression with the corresponding class.

Gene Expression
Patient ID

LIN52

PCOTH

GRM1

SLC9A1

….

CD164

Class

MB-0000

6.006671 5.640276 5.322082

9.364857

….

6.523877

N3

MB-0002

7.263404 5.807551 5.418732

11.19858

….

6.687907

N0

MB-0005

6.323518 5.455436

5.51028

9.199171

….

5.688272

N1

MB-0006

6.409583 5.572757 5.199104

9.334389

….

5.845664

N1

MB-0008

6.414613 5.721091 5.061777

9.529512

….

5.870183

N2

MB-0010

6.563254 5.449545 5.380782

8.887233

….

5.712453

N0

MB-0014

6.812145 5.645348 5.287389

8.90297

….

5.751436

N1

MB-0020

6.657678 5.635089 5.291151

9.858843

….

6.44788

NX

MB-0022

5.961513 5.551212 5.153493

9.508277

….

5.802332

N1

…

…

…

….

….

…

…

…
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Appendix B: ANN Python Code
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